Research Management Group (RMG)

National Cancer Institute
Administrative supplements for P30 Cancer Center Support Grants to advance rural cancer control research capacity in clinic settings 
*Request for internal proposals*

 Limited submission program-only one supplement request per center will be considered. Dr. Steve Artandi, the Director of the Cancer Institute, the PI for the Stanford Cancer Institute P30 Cancer Center Support Grant, will submit the administrative supplement on behalf of the proposal selected through this internal selection process.


# of administrative supplements permitted: Only one supplement request per center will be considered.



Timeline:

Internal SCI deadline:  Monday, April 22, 2019, 3 p.m.  (see internal submission guidelines below)
Applicant notified by SCI: 
For applicant selected: 
PI to submit your Proposal Intake Form (PIF) in SeRA asap
Institutional representative (RPM/RMG) deadline:  May 13, 2019
Administrative supplement deadline: May 20, 2019

 

Eligibility:  

Amount of funding:
Supplement requests may not exceed $200,000 total costs. 
Awards will be based on responsiveness to this announcement, the range of applications representing different regions of the United States, and the availability of funds. It is anticipated that awards for this supplement opportunity will be made in the summer of 2019.  


Background

Overall cancer mortality rates in the U.S. are higher in rural than in urban areas, a disparity that is worsening. Many rural communities face several challenges, including high poverty, low educational attainment, and lack of access to health services. Some of the higher incidence and mortality rates for cancer in rural areas can be attributed to barriers in accessing health services. Research also has shown that some of these barriers relate to financial hardships (e.g., lack of insurance or insufficient insurance coverage), transportation, and the lower availability and utilization of preventive and screening services in rural areas. Also, rural residents often manifest higher rates of tobacco use, alcohol consumption, and obesity, low levels of physical activity, low adoption of sun safety behaviors, and low HPV vaccination rates. All these challenges contribute to higher incidence of certain cancers and worse cancer-related outcomes in low-income, underserved rural populations.



Purpose 

The National Cancer Institute (NCI), Division of Cancer Control and Population Sciences (DCCPS), announces the opportunity for recipients of NCI-funded P30 Cancer Center Support Grants to submit requests for administrative supplements to enhance research capacity in rural cancer control to conduct studies in collaboration with key rural health care clinic and/or safety net providers serving low-income and/or underserved rural populations and/or Native American populations.

Definitions: For purposes of this announcement rural clinics include rural health care safety net providers such as Critical Access Hospitals (CAHs), other small rural hospitals, Federally Qualified Health Centers (FQHCs), Medicare-certified Rural Health Clinics, as well as those clinics and hospitals that serve tribal populations, and those that provide care to rural populations through primary care clinics within a larger health care system. Small rural hospitals are defined as general acute care hospitals of 50 beds or less.  For the purposes of this supplement, Native Americans (NA) include the following populations: Alaska Native, American Indian, and Native Hawaiian. The term “Native Hawaiian” means any individual any of whose ancestors were natives, prior to 1778, of the area that now comprises the state of Hawaii.

The purpose of this opportunity is to provide resources to support the time and effort of teams at NCI-Designated Cancer Centers, in collaboration with clinics that serve rural and/or NA populations, to plan, implement, and sustain a rural cancer control research program that focuses on rural low-income and/or underserved populations. As such, awardees will be expected to address challenges and opportunities related to working in partnership with rural clinics and enhance delivery of cancer control and prevention strategies to improve overall health and lessen the burden of cancer. The long-term goal of this supplement is to build the capacity for cancer prevention and control research and the implementation of evidence-based programs and practices focused on low-income and/or underserved populations in rural and/or NA communities.

There are several areas where NCI can play a significant role in advancing rural cancer prevention and control research, despite rural health being a complex issue with many competing challenges and comorbidities.These supplements are a part of a larger NCI research initiative to inform, test and strengthen cancer control programs that are sustainable in these communities across the United States.

*To be considered responsive for supplemental funding, centers are to adopt the 2013 Rural Urban Continuum Code (RUCC) definition (https://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx) to designate rural areas (codes 4-9). Special consideration will be given to those centers that include or have a primary focus in populations that reside in RUCC categories 7, 8, and 9. Applicants should also justify how their grant addresses a rural population that is also primarily low-income and/or underserved. Applicants should also clearly demonstrate collaboration and provide support for the work of proposed partners and stakeholders. Comparisons to urban populations are not responsive to this opportunity.  
Applicants proposing to work with AI/AN tribes/communities/clinics are required to submit letters of support and, if funded, obtain tribal resolutions before beginning data collection.

 

Goals of This Supplement 
The primary aims of this supplement opportunity are 1) the successful development of a collaboration with rural clinics (defined above*) to conduct studies in cancer prevention and control; 2) data compilation, analyses, and/or integration; 3) collection of preliminary data for research proposals and/or for pilot projects in cancer control; and 4) to enhance and study implementation of programs for research in cancer prevention and control in rural clinics.

Many rural safety net providers are focused on delivery of primary care, and as such, may have limited research infrastructure or previous experience participating in cancer prevention and control research. Cancer centers are encouraged to work with these clinics to build and implement a cancer prevention (primary and secondary) and control research agenda. Projects may focus on one or more of the cancer control continuum areas including survivorship. Partnerships with community-affiliated clinics or hospitals; state offices of rural health; area health education centers; state rural health associations; primary care networks or associations; departments of health, education, or human services; and other community organizations are strongly encouraged. Engagement of clinic partners, community advisors, and other relevant stakeholders are encouraged. By supporting more preliminary work and pilot projects, NCI hopes to ultimately increase the funded grant portfolio focused on rural populations. 

These supplements are not intended to be focused on community outreach or building community awareness for cancer control programs. Projects should focus on clinic-based rural cancer control research program development.

 

Application Submission Format
Applications may be submitted as a signed, scanned PDF to Crystal Wolfrey (wolfreyc@mail.nih.gov) and Stacey Vandor (stacey.vandor@nih.gov) no later than COB May 20, 2019. 

Requests must include the following:

 

The 5-page summary should (for the administrative supplement)

For those who received a previous rural P30 supplement, please include an additional one-page progress report (6th page) of the accomplishments in the first round of funding.

Scientific Requirements
Proposals will be reviewed by NCI staff experts for quality and for responsiveness to application criteria outlined above.

NCI will only consider requests for supplements that include the following:

Applications may also include the following:

Reporting Requirements
As part of the progress report for the parent cancer center grant, information must be included on what has been accomplished via the administrative supplement (program details such as conceptual framework; tactics implemented; workflow incorporation; sustainability actions; progress on timeline tasks; and results from standardized evaluation measures on screening, reach, uptake, and other noted measures), as well as progress on the cancer center’s work and sustainability plans. Project leaders and their rural and/or NA partners (at least two from each cancer center) should plan to attend twice-annual meetings, where they will be expected to present their findings to other awardees of these supplements.

Questions
For technical inquiries, please contact your cancer center support grant program director. For inquiries about the scientific objectives and goals of this supplement, please contact Shobha Srinivasan (ss688k@nih.gov).

 

INTERNAL STANFORD CANCER INSTITUTE SUBMISSON GUIDELINES:

By April 22, 2019, 3 p.m., please CLICK HERE to upload one PDF file [File name: Last name_NCI_Rural_supplement_2019.pdf] containing the following (in the order listed below) to the Stanford Medicine Box Submission folder.

Questions?
Denise Baughman
Project Manager, Stanford Cancer Institute
deniseb@stanford.edu

Note: you do not have to submit your internal proposal through your institutional representative (RPM/RMG) for his or her approval, you can submit it directly to Denise per these instructions.

1) Title page
NIH NCI Administrative supplements for P30 Cancer Center Support Grants to advance rural cancer control research capacity in clinic settings 
Project title
Name of the PI’s and Co-PIs, title, department, contact information, address, email, phone #

2) Research proposal up to 5 pages (based on the above NCI guidelines)
Formatting: single-spaced,  Arial/Helvetica font size 11

 

3) PI's  and  Co-Pis Biosketch

4) PI's Other funding (this must include your current or pending other support: name of sponsor, term, amount of funding)

 


Selection process

Your proposals will be reviewed by the Stanford Cancer Institute review committee.  Dr. Steve Artandi, the Director of the Cancer Institute, the PI for the Stanford Cancer Institute P30 Cancer Center Support Grant, will submit the administrative supplement on behalf of the proposal selected through this internal selection process.

 


Footer Links: